Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): secondary endpoints from a randomised phase 3 factorial trial-Reference-Cited by-同舟云学术

Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): secondary endpoints from a randomised phase 3 factorial trial

Published:2012-12 Issue:12 Volume:13 Page:1260-1270
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Denham James W,Wilcox Chantelle,Joseph David,Spry Nigel A,Lamb David S,Tai Keen-Hun,Matthews John,Atkinson Chris,Turner Sandra,Christie David,Gogna Nirdosh Kumar,Kenny Lizbeth,Duchesne Gillian,Delahunt Brett,McElduff Patrick

Publisher

Elsevier BV

Subject

Oncology

Reference33 articles.

1. Long-term followup of a randomized study of locally advanced prostate cancer treated with combined orchiectomy and external radiotherapy versus radiotherapy alone;Granfors;J Urol,2006

2. Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma-long-term results of phase III RTOG 85-31;Pilepich;Int J Radiat Oncol Biol Phys,2005

3. Phase III Radiation Therapy Oncology Group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate;Pilepich;Int J Radiat Oncol Biol Phys,2001

4. Androgen suppression and radiation vs radiation alone for prostate cancer;D'Amico;JAMA,2008

5. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial;Bolla;Lancet,2002

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Short-term Darolutamide (ODM-201) Concomitant to Radiation Therapy for Patients with Unfavorable Intermediate-risk Prostate Cancer: The Darius (AFU-GETUG P15) Phase 2 Trial Protocol;European Urology Oncology;2024-05

2. Persistent deficiencies in the measurement and reporting of tobacco use in contemporary genitourinary oncology clinical trials;Cancer Epidemiology;2021-10

3. A prospective analysis of health-related quality of life in intermediate and high-risk prostate cancer patients managed with intensity modulated radiation therapy, with vs. without hormonal therapy;Urologic Oncology: Seminars and Original Investigations;2020-10

4. Harnessing the patient voice in prostate cancer research: Systematic review on the use of patient‐reported outcomes in randomized controlled trials to support clinical decision‐making;Cancer Medicine;2020-04-25

5. Quality-of-Life Assessment and Reporting in Prostate Cancer: Systematic Review of Phase 3 Trials Testing Anticancer Drugs Published Between 2012 and 2018;Clinical Genitourinary Cancer;2019-10